Bot Image, Inc
Bot Image, Inc., based in Omaha, NE, is at the forefront of revolutionizing medical imaging with its innovative artificial intelligence technology, which aims to enhance early detection and precise diagnosis of prostate cancer. Their flagship product, ProstatID, is the first FDA-cleared AI software in North America for prostate cancer screening, offering advanced diagnostic capabilities that assist physicians in understanding disease severity non-invasively.
The company also provides the MaleScan service, enabling patients and their physicians to upload MRI scans and receive AI-supported diagnostic reports quickly. Through a commitment to improving healthcare efficiencies and patient outcomes, Bot Image, Inc. continues to lead advancements in AI-assisted prostate cancer diagnosis, bringing precision and speed to critical medical processes.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.

